Archive | Clinical Trials

Pembrolizumab Plus Reduced Ipilimumab Dose Active in Advanced Melanoma

The combination of standard-dose pembrolizumab with four reduced doses of ipilimumab followed by standard-dose pembrolizumab had a manageable safety profile and antitumor activity in patients with advanced melanoma, according to the results of the phase Ib KEYNOTE-029 study published in Lancet Oncology.

Read the full story

Posted in Melanoma In The News, Clinical Trials

Herpes Virus Targets Metastatic Melanomas in the Brain

A novel method that harnesses the power of viruses shows promise targeting skin cancer metastases in the brain. In a study published in PNAS, the investigators developed cancer-killing viruses that can deliver stem cells via the carotid artery.

Read the full story

Posted in Melanoma In The News, Clinical Trials

Reflectance confocal microscopy may improve lentigo maligna diagnosis

Reflectance confocal microscopy was associated with high sensitivity and specificity in diagnosing lentigo maligna, according to published study results in JAMA Dermatology.

Read the full story

Posted in Melanoma In The News, Clinical Trials

Delayed sentinel lymph node biopsy safe after melanoma diagnosis

Postponement of sentinel lymph node biopsy more than 30 days after melanoma diagnosis did not have a negative effect on long-term survival, according to study results.

Read the full story

Posted in Melanoma In The News, Clinical Trials

Melanoma Google Alerts

Melanoma Google Alerts is a summary of daily articles found in print and on the internet. The articles do not necessarily represent the views of Melbourne Melanoma Project

News Archives

News Categories